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ABSTRACT 
 
PRRXL1 is a paired-like homeodomain transcription factor expressed in nociceptive 
neurons of dorsal root ganglia and dorsal spinal cord. Evidence shows that PRRXL1 is crucial in 
the establishment and maintenance of the nociceptive system, as Prrxl1
-/-
 mice present neuronal 
loss, reduced nociception and failure to thrive. In this study it is shown that PRRXL1 is highly 
phosphorylated in vivo, and that its multiple band pattern on electrophoretic analysis is the result 
of different phosphorylation states. These phosphorylations evolve along spinal cord and dorsal 
root ganglia development from a higher to a lower phosphorylated state, and are mapped to 
aminoacid regions 1-143 and 227-263. PRRXL1 also displays a conformation, a dimerization 
and a repressor domain, which altogether act in concert to modulate its transcriptional activity. 
Phosphorylation is therefore proposed as a mechanism for regulating PRRXL1 function and 
conformation during nociceptive system development. 
 
Keywords: Development; nociceptive system; phosphorylation; Prrxl1 
 
 
ABBREVIATIONS 
 
CIAP: calf intestinal alkaline phosphatase 
DRG: dorsal root ganglion 
dSC: dorsal spinal cord 
IEF: isoelectric focusing 
IMAC: immobilized metal affinity chromatography 
NLS: nuclear localization sequence 
OAR: otp, aristaless and rax 
Rf: electrophoretic mobility 
WB: western blotting 
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INTRODUCTION 
 
Pain is defined as “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage” [1]. Although the 
functional maturation of higher brain centres is needed for complete pain awareness and 
response, that would not be possible without the existence of a properly established spinal 
nociceptive circuitry [2]. This circuitry is important for the adequate relay of sensory 
information from the peripheral tissues to the brain, and its embryonic development is regulated 
by the combinatory expression of transcription factors, which specify distinct neuronal 
populations. The expression of morphogens and their receptors, basic Helix-loop-Helix 
transcription factors and, later, homeodomain transcription factors shapes the dorsal spinal cord 
(dSC) into its laminated cellular pattern and divides the dorsal root ganglion (DRG) into three 
main neuronal populations [3,2]. The ensuing DRG/spinal nociceptive circuit is therefore 
composed by small diameter primary afferent neurons that project to the superficial laminae of 
the dSC. 
The molecular mechanisms responsible for the proper establishment of these neuronal 
connections are not yet fully understood. Paired-related homeobox protein-like 1, or Prrxl1 
(also known as Drg11), is a gene encoding for a transcription factor that is involved in the 
establishment and maintenance of the DRG-dSC nociceptive circuitry during embryonic 
development [4]. It is expressed in the DRG, dSC, cranial sensory ganglia and brainstem 
sensory nuclei [5]. Prrxl1
-/- 
mouse embryos exhibit spatio-temporal abnormalities in the 
patterning of sensory afferent fibre projections to the dSC, as well as loss of dorsal horn 
neurons. Post-natally, Prrxl1 null mutant mice present significantly attenuated sensitivity to 
noxious and thermal stimuli, with reduced sensitivity to mechanical stimulation and chemical 
nociception. The apparent absence of alterations in motor function and locomotion suggests that 
proprioception and mechanical innocuous processing are not influenced by PRRXL1 [4]. At the 
cellular level, PRRXL1 seems to be important for the survival of peptidergic and non-
peptidergic small DRG neurons, as opposed to large DRG neurons [6]. Prrxl1 expression 
markedly decreases after birth, being residual in adult life. However, post-natal expression is 
increased in inflammatory, but not neuropathic pain, at the expense of peptidergic and non-
peptidergic small DRG neurons [7].  
Although the role of PRRXL1 in the development of the DRG/dSC circuit has been well 
established, the mechanisms underlying the modulation of PRRXL1 transcription activity 
remain unstudied. PRRXL1 western blotting (WB) analysis of SC and DRG extracts revealed a 
pattern of multiple bands [5], which may indicate the occurrence of post-translational 
modifications such as phosphorylation [8]. In fact, more than 400 types of post-translational 
modifications can occur, with the most common occurring in eukaryotic cells being 
phosphorylation [9]. Protein phosphorylation is a major mechanism by which transcription 
factor activity is regulated. Moreover, it seems to be the post-translational modification of 
choice when rapid modulation of transcription factor activity is required [10]. Protein 
phosphorylation is known to regulate several cellular processes, namely cell growth and 
division, differentiation, signal transduction and gene expression [11]. 
The present study shows that PRRXL1 band pattern is due to multiple phosphorylation 
states that vary along DRG and dSC development. Analysis of several PRRXL1 truncated forms 
suggests that PRRXL1 has two phosphorylation clusters, with an overall number of at least 6 
phosphorylated residues. These phosphorylations seem to be responsible for changes in protein 
conformation and thereby transcriptional activity. Overall, this work comes a step closer to 
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uncovering the molecular mechanisms underlying the regulation of PRRXL1 function in the 
establishment of the nociceptive circuitry. 
 
 
MATERIALS AND METHODS 
 
Animal care and Tissue Harvesting - NMRI mice were bred and fed ad libitum with a standard 
diet and housed at the IBMC animal facility under temperature- and light-controlled conditions. 
Embryonic day 0.5 (E0.5) was considered to be the midday of the vaginal plug. The animals 
were euthanized (isoflurane anesthesia followed by cervical dislocation) and embryos surgically 
removed. The SC and DRG were collected and the SC dissected into their dorsal and ventral 
moieties, except for E10.5 embryos, where the prospective SC was used. Experiments complied 
with the European Community Council Directive (86/609/EEC) and the animal ethics 
guidelines at IBMC. The Portuguese Veterinary Ethics Committee approved all animal 
manipulations. 
1 dimensional (1D) and 2 dimensional (2D)-PAGE sample preparation - dSC nuclear lysates 
for 1D-PAGE were obtained as previously described [5]. dSC and DRG were homogeneized in 
2D lysis buffer (20 mM phosphate buffer pH 8.0, 0.1% Triton X-100) supplemented with 
phosphatase and protease inhibitors (Sigma-Aldrich) and Benzonase nuclease (Novagen), 
sonicated and cleared by centrifugation. Isoelectric focusing (IEF) was performed on a Protean 
i12 Cell (Bio-Rad) using 11 cm immobilized pH gradient strips pH 3-10 non-linear (Bio-Rad) 
for 38.000 VH, held at 750 V and frozen until processing. The low-bis SDS-Polyacrilamide gels 
(10-16%T/1.35%C) were ran, and WB was performed using standard protocols. Rabbit anti-HA 
(Invitrogen #715500), homemade rabbit anti-PRRXL1 [5], mouse anti-FLAG M2 (Sigma-
Aldrich #F1804), mouse anti-α-tubulin (Sigma-Aldrich #T5168) and rabbit anti-Histone H3 
(Abcam #ab1791) were used as primary antibodies. Appropriate HRP conjugated secondary 
antibodies (Jackson Immunoresearch Europe) or Clean-Blot IP Detection Reagent (Pierce) were 
used. All quantitative blot analyses were performed using ImageLab v4.1 (Bio-Rad 
Laboratories).  
Dephosphorylation assays - Samples homogeneized in dephosphorylation buffer [12] were 
incubated with calf intestinal alkaline phosphatase (CIAP) (Invitrogen) for 2 h at 37ºC. A 
competitive inhibitor, 20 mM Na2HPO4, was added to a replicate reaction mix as a control. IEF 
samples were prepared using ReadyPrep™ 2-D Cleanup Kit (Bio-Rad).  
Ga(III)- immobilized metal affinity chromatography (IMAC) - The matrix was generated using 
IMAC-Select Affinity gel (Sigma-Aldrich) and GaCl3. The gel was washed in 50 mM EDTA/1 
M NaCl and charged with 100 mM GaCl3 in 100 mM acetic acid. It was washed with 5% acetic 
acid followed by 0.5 M NaCl and H2O washes. GaCl3 was not added to the control matrix. 
Nuclei were lysed in IMAC lysis buffer (15 mM MES/NaOH pH 5.5, 0.5 M NaCl, 1% NP-40, 
protease inhibitor cocktail). Matrix was equilibrated in IMAC buffer (50 mM MES/NaOH 
pH5.5, 0.5 M NaCl, 1% NP-40) and extracts (0.1 µg/µL) were incubated for 2 h at 4ºC. After 
washing, elution was performed by adding 0.2 M Phosphate buffer pH 8.0 [modified from 13]. 
The input and collected fractions were TCA-precipitated prior to analysis.  
GST- PRRXL1 generation and purification - BL21 E. coli transformed with pGEX-4T3-Prrxl1 
were induced, lysed (PBS, 0.5% Triton, 1 mM DTT and inhibitor cocktails), incubated 2 h at 
20ºC with a glutathione-cellulose matrix (Bioline) and eluted with thrombin (Novagen). The 
SDS-PAGE gel of the eluate was reverse stained with Zn
2+
 [14] and the PRRXL1 band was 
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excised. PRRXL1 was eluted from the gel by diffusion overnight at 4ºC in  0.01% SDS/20 mM 
Tris-HCl pH 7.5, TCA–precipitated, ressuspended in 2% SDS and dialyzed against a 10 mM 
Tris-HCl pH 7.5, 0.01% n-octyl-β-D-glucoside solution, to allow renaturation of the fusion 
protein.  
Prrxl1 constructs - Full-length and N/C-terminal truncations of Prrxl1 (EU670677.1) were 
amplified from mouse E14.5 SC cDNA and cloned into pCDNA3.3-TOPO TA (Invitrogen). 
The HA- and FLAG-tag were added to the primers (see Supplementary Table 1). All constructs 
were sequenced.  
Cell culture - ND7/23 and HeLa cell lines were cultured at 37ºC/5ºCO2 in DMEM (Gibco) 
containing 10% FBS (Gibco) and 50 U/ml penicillin and streptomycin (Gibco). Transfection 
was performed using Lipofectamine 2000 (Invitrogen) and cells were harvested 24 h later.  
Luciferase reporter assays – 48 h after transfecting ND7/23 or HeLa cells with different 
constructs of PRRXL1, pCMVβ (Clontech) and pGL3 (Promega) containing Firefly Luciferase 
under the control of the Rgmb promoter sequence [15], cells were resuspended in 50 µl of lysis 
buffer (Promega) and the protein extract cleared by centrifugation. 5 µl were mixed with the 
luciferase reagent (Promega) and luminescence measured by an Infinite M200 plate reader 
(Tecan). Transfection efficiency was normalized by assessing β-gal activity using ONPG 
(Sigma-Aldrich) as substrate and read at 420 nm.  
Cyanogen bromide (CNBr) cleavage assay - ND7/23 cells overexpressing PRRXL1-HA, lysed 
in a 1% Triton X-100, 0.1% SDS buffer were incubated for 20 or 90 min with 10 volumes of a 
100 mg/mL CNBr solution in 70% formic acid. Afterwards, 10 volumes of 10% TCA in acetone 
were added, incubated for 1 h at -80ºC, centrifuged at 21,100g for 30 min and washed twice in 
acetone. Precipitate was resuspended in adequate downstream buffer [modified from 16]. 
DNA-protein interaction studies – 50 µg of transfected ND7/23 cell extracts were incubated 
overnight at 4ºC with 150 ng of biotinylated Rgmb promotor sequence [15] (PCR-generated 
using biotinylated primers) and 1 μg of Salmon sperm DNA (Sigma Aldrich), in a volume of 
100 µL of wash buffer (TBS, 5% BSA, 0.05% Tween-20). Control reactions omitted the DNA 
probes. The reaction mix was incubated for 2 h at room temperature in NeutrAvidin
 
coated 96-
well plates (Pierce) and washed. Anti-HA antibody 1/1000 was added for 3 h at room 
temperature, followed by washing and 1 h incubation with a 1/5000 dilution of HRP-conjugated 
goat anti-rabbit antibody. WestPico Chemiluminescent substrate (Pierce) was added and 
luminescence measured after 2 min on an Infinite M200 reader (Tecan).  
Ferguson Plot - Ferguson plot analysis can distinguish a change in the shape of a protein from a 
change in the charge. By running ND7/23 extracts overexpressing PRRXL1-HA in SDS-PAGE 
at various concentrations of acrylamide (10 to 16%, w/v), the logarithm of the electrophoretic 
mobility (Rf) was plotted versus the acrylamide concentration. The slope and y-axis intercept 
depend on the electrical charge of the protein and on the shape, defined as the Stokes radius 
(effective hydrated radius of the protein-SDS complex). Proteins differing only in the 
conformation give different slopes with a common y-axis intercept whereas proteins differing 
only in the electrical charge have identical slopes with different y axis intercepts [17,18]. Linear 
regression was performed in Microsoft Excel 2010
®
.  
Limited tryptic digestion - ND7/23 cells overexpressing Prrxl1 lysed in TBS-0.1%, Triton X-
100 were incubated with TPCK-treated trypsin (Sigma-Aldrich #T1426) at ratios of 1:100 to 
1:400 (w/w). The reactions were performed in 0.05% BSA, 50 mM Tris-HCl pH 8.0, 20 mM 
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CaCl2 and  0.5 mM DTT at 37ºC during 15 min, after which 5 mM AEBSF and sample buffer 
were added. Peptides were resolved by 16% SDS-PAGE.  
Cycloheximide time-course - ND7/23 cells were reverse-transfected with pCDNA3.1-Prrxl1. 
After 12 h, the cells were incubated with cycloheximide (100 µg/ml) for 1 to 6 h and the lysates 
analysed by WB.  
Sub-cellular fractionation of Prrxl1 constructs – ND7/23 cells transfected with different Prrxl1 
constructs were lysed in nuclear fractionation buffer (0.25 M sucrose, 20 mM Tris-HCl pH 7.4, 
0.1% Triton X-100 and protease and phosphatase inhibitors), gently homogeneized and 
centrifuged at 1000g for 10 min at 4ºC. Equivalent amounts of total, cytosolic and nuclear lysate 
were loaded.  
Immunocytochemistry of constructs – ND7/23 cells transfected with different Prrxl1 constructs 
were fixed in 4% PFA in PBS, permeabilized using 1% Triton X-100 in PBS, blocked with 10% 
NGS in PBS/0.1% Triton and incubated overnight at 4ºC with anti-PRRXL1. Alexa 594 
conjugated goat anti-rabbit IgG (Molecular Probes) was used as secondary antibody and DAPI 
was used as a nuclear counterstain.  
Co-immunoprecipitation - ND7/23 cells were co-transfected with PRRXL1-FLAG and several 
HA-PRRXL1 truncated constructs. Lysates in co-immunoprecipitation buffer (TBS, 0.1% 
Triton X-100, 10% glycerol and protease and phosphatase inhibitors) were immunoprecipitated 
using ANTI-FLAG M2 Magnetic Beads (Sigma-Aldrich) and eluted in Sample Buffer.  
Statistical analysis – Students t-test was used and the p-values indicated result from at least 3 
independent experiments. All error bars represent standard deviation. 
 
 
RESULTS 
 
PRRXL1 displays a delayed electrophoretic migration due to phosphorylation 
PRRXL1 WB analysis showed the presence of multiple bands [5] that are suggestive of 
post-translational modifications [8,19]. This is further supported by the fact that PRRXL1 
expressed in Escherichia coli displayed a single band, when compared to E14.5, which 
displayed a higher molecular-weight duplet (fig. 1a). As the most common post-translational 
modification in eukaryote organisms is phosphorylation [9], it was hypothesized that the 
PRRXL1 band pattern could be due to phosphorylation. Therefore, nuclear extracts of dSC from 
E14.5 embryos were treated with CIAP. The phosphatase treatment reproducibly eliminated the 
alteration in migration, revealing an increasing amount of dephosphorylated PRRXL1 (lower 
molecular-weight band) with increasing units of CIAP. The addition of a competitive inhibitor 
(Na2HPO4) prevented this effect, maintaining PRRXL1 band pattern (fig. 1b). Thus, 
phosphorylation is responsible for the delayed migration of the observed PRRXL1 forms. To 
further reinforce this observation, E14.5 and post-natal day 0 (P0) dSC nuclear extracts were 
subjected to Ga(III) IMAC, a resin that binds phosphoproteins [13]. These ages were chosen 
because they are representative of different PRRXL1 band patterns. As depicted in figure 1c, the 
E14.5 and P0 eluted fractions displayed an enrichment of the upper bands, and only the lower 
bands (the more dephosphorylated bands) were detected in the unbound fraction (flowthrough). 
While providing an important internal control, this demonstrates that the multiple band pattern 
represents a gradient of differentially phosphorylated forms, with higher phosphorylation states 
in the upper bands. This also explains the absence of dephosphorylated PRRXL1 in dSC E14.5 
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incubated with Ga(III), as PRRXL1 expressed in this age displays only highly phosphorylated 
forms. 
The ND7/23 cells are a hybrid cell line derived from neuroblastoma and P0 DRG 
neurons that displays sensory neuron-like properties [20]. It also endogenously expresses 
PRRXL1, although at low levels [21]. Lysates of ND7/23 cells overexpressing Prrxl1 were 
incubated with CIAP and resolved by SDS-PAGE (fig. 1d). Untreated PRRXL1 displayed a 
multiple band pattern similar to P0 DRG. As expected, incubation of PRRXL1 with CIAP 
abrogated upper bands, and Ga(III)-IMAC purification confirmed an enrichment of the upper 
bands (fig. 1e). Therefore, the ND7/23 cell line is a suitable model for further study of PRRXL1 
phosphorylations. 
 
PRRXL1 acquires distinct phosphorylation states along development 
When mouse dSC and DRG protein extracts from different developmental stages are 
resolved by WB, a differential multiple band pattern can be observed (fig. 2a). Overall, four 
bands can be identified, henceforth referred to as band 1 to 4 from the slowest to the fastest 
migrating band. At early developmental ages (E10.5 to E14.5), when neuronal specification and 
migration is occurring [3], only the two upper bands (bands 1 and 2) were detected both in the 
dSC and in the DRG (fig. 2a). From E16.5 onwards, a developmental period where neurons 
have migrated and are differentiating [3], there is a progressive change of PRRXL1 upper band 
toward lower bands (bands 3 and 4). However, while in the dSC there is loss of the upper 
migrating band (bands 1 and 2) from E16.5 onwards, in the DRG, the upper bands fade only 
after birth, while band 3 increases at P14 and P21. This differential evolution of phosphorylation 
patterns in the dSC and in the DRG along nociceptive system development suggests that 
PRRXL1 plays a specific role in each tissue. 
 To improve the resolution of our analysis, several protein extracts were subjected to 2D 
electrophoresis, a technique combining IEF followed by SDS-PAGE (fig. 2b). The IEF 
separates proteins according to their isoelectric point (pI). It can detect individual 
phosphorylated forms, since each additional phosphate increases the negative charge of the 
protein, thus causing a shift in pI [22]. Therefore, by using IEF, one can monitor the 
phosphorylation state of a protein as indicated by the shifts in the pI. For this analysis, samples 
from E14.5, E16.5, P0 and P14 mice were used, as these developmental ages seem 
representative of all PRRXL1 phosphorylation states. The 2D electrophoresis resolved PRRXL1 
into a detectable maximum of 7 different spots, which drift towards the anode (fig. 2b). The 
number of phosphorylated residues for each spot was determined by considering the predicted 
shift provided by each phosphorylation [23], the expected position in the 3-10 pH gradient and a 
dephosphorylated E14.5 dSC extract (fig. 2b, CIAP control), where only one spot is seen in the 
region of PRRXL1 theoretical pI (8.74). Therefore, each spot corresponds to different PRRXL1 
phosphorylated forms.  
In accordance to the observation that PRRXL1 phosphorylated forms vary along 
development, it is evident that the relative abundance of each spot also changed, and differed 
between samples. When comparing E14.5 with E16.5 and P0 dSC samples, the intensity of two 
spots (arrows in fig. 2b, corresponding to 2 and 4 phosphorylated residues) decreased from 
E14.5 to E16.5 and was undetectable at P0. These spots are part of the upper bands from the 1D 
analysis (fig. 2a/b, diagrams). On the other hand, the lower bands were only detected at post-
natal ages. In the dSC, band 4 is the only one of the lower duplet detected in 1D SDS-PAGE 
(fig. 2a), giving rise to a spot that migrates in a region of the immobilized pH gradient strip 
corresponding to one phosphorylated residue (fig. 2b). The PRRXL1 expressed in ND7/23 cells, 
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however, displayed spots corresponding to 6 phosphorylated residues, and is most similar to the 
spot pattern of dSC P0. The progressive disappearance of particular spots explains the previous 
finding that, as development progresses, PRRXL1 tends to exist in a less phosphorylated state. 
It also suggests that specific phosphorylation states are favoured over others at different stages, 
and may be mutually interdependent. 
 
PRRXL1 acquires phospho-dependent conformational changes 
The fact that the SDS-PAGE resolved phosphorylated PRRXL1 forms with the same 
isoelectric point (and hence the same number of phosphorylated sites) but with different 
electrophoretic mobility (fig. 2b, ND7/23) suggests that the electrostatic charge conferred by the 
presence of multiple phosphate groups is not the sole responsible for PRRXL1 multiple band 
pattern. This mobility shift could in fact be the result of different protein conformations that rely 
on phosphorylation at key residues [8].  
To further address this issue, the phosphorylation-induced gel shift was studied using 
the Ferguson plot approach [17,18], by carrying out SDS-PAGE at different acrylamide 
concentrations and plotting the log(Rf) as a function of acrylamide concentration (Table 1). The 
Rf is proportional to the net charge of the protein and inversely proportional to its Stokes radius. 
If the mobility decrease was caused only by an alteration in the charge due to phosphorylation, 
it would be independent of the acrylamide concentration (for further details please refer to the 
Materials and Methods section). However, the difference in the slopes of the Rf of the lower 
(bands 3/4) versus the higher (bands 1/2) phosphorylated state of PRRXL1 suggests that 
phosphorylation causes a change in protein Stokes radius and thus in protein structure. In fact, 
there is an Rf decrease with decreasing pore size. This supports the previous hypothesis that 
PRRXL1 suffers conformational changes, likely induced by phosphorylation. 
To further support this observation, the susceptibility of PRRXL1 bands to limited 
tryptic digestion was used as a conformational probe. ND7/23 extracts overexpressing Prrxl1 
were incubated with different amounts of trypsin and the signal intensity of bands 1/2 and 3/4 
was estimated (fig. 3a). The fast migrating bands (bands 3/4) correspond to a less 
phosphorylated status and were more resistant to enzymatic digestion than the more 
phosphorylated bands (bands 1/2), whose expression diminishes with increasing trypsin 
amounts. This result suggests that phosphorylation favours a local conformational change that at 
least partially alters PRRXL1 structure, with increased exposure of more proteolitically 
sensitive residues. Furthermore, when ND7/23 cells overexpressing Prrxl1 were treated with 
cycloheximide (which inhibits protein synthesis by blocking translational elongation; fig. 3b), 
there was a decrease of the upper bands’ level over time, in comparison with the lower bands. 
These observations suggest that highly phosphorylated PRRXL1 is less stable. 
 
PRRXL1 homodimerizes and has two phosphorylation clusters 
Aiming at identifying the main PRRXL1 phosphorylated regions, several truncated 
forms of HA-PRRXL1 were generated (fig. 4a) and the nuclear translocation of the constructs 
was assessed (fig. 4b/c). It has been suggested that paired-like homeodomain transcription 
factors contain a bipartite nuclear localization sequence (NLS) motif flanking the homeodomain 
region [24]. In fact, all PRRXL1 truncations containing the homeodomain/NLS sequence 
translocated to the nucleus, while versions with deletion in this region remained in the 
cytoplasm. However, a small amount of PRRXL1107-263 was still translocated to the nucleus 
despite the deletion of the homeodomain, while all PRRXL1189-263 remained in the cytosol (fig. 
4c). This could be explained by dimerization of the truncated form with endogenous PRRXL1 
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or other transcription factors, as paired-like homeodomain proteins usually act as dimers to form 
a functional DNA-binding domain [25].  
To identify a putative PRRXL1 dimerization domain, co-immunoprecipitation studies 
were performed with ND7/23 cell extracts co-expressing full-length PRRXL1-FLAG and the 
different truncated forms of HA-PRRXL1. As visible in figure 4d, PRRXL1 
immunoprecipitated with itself and with PRRXL11-227, PRRXL11-180 and PRRXL1107-263 
truncated forms. This implies that these three truncations have a sequence capable of binding 
PRRXL1. However, PRRXL11-143 was not capable of binding, together with PRRXL1189-263, 
which are constructs lacking aminoacids 143-180. This indicates the 143-180 region as the 
likely site for PRRXL1 homodimerization, supporting the possibility that PRRXL1107-263 partial 
nuclear translocation is due to dimerization with endogenous PRRXL1. 
Analysis by 2D-electrophoresis of ND7/23 cells overexpressing different PRRXL1 
truncations revealed a similar 3-spot pattern for PRRXL11-227, PRRXL11-180 and PRRXL11-143 
truncated forms (fig. 5a). On the other hand, PRRXL1 C-terminal constructs (PRRXL1107-263 
and PRRXL1189-263) displayed a highly phosphorylated pattern, containing 5 distinct spots. 
These phosphorylations occurred in the cytoplasm, since the PRRXL1189-263 truncated protein 
was not targeted to the nucleus (fig. 4b/c). These findings suggest that there are at least two 
phospho-sites between aminoacids 1-143 and four phospho-sites from aminoacids 189 onwards. 
In fact, as PRRXL11-227 truncation displayed a similar spot pattern as the other N-terminal 
constructs, the majority of the C-terminal phosphorylations must occur from aminoacid 227 
forward. 
To further study this PRRXL1 C-terminal phosphorylation, a chemical cleavage assay 
with CNBr, which cuts at methionine residues (fig. 5b), was performed. To identify the cleaved 
fragments, ND7/23 cells overexpressing PRRXL1-HA fusion protein were shortly incubated (20 
minutes) with CNBr (fig. 5b) and compared with the migration of PRRXL1107-263 and 
PRRXL1189-263 constructs. The small amount of the PRRXL169-263 on WB suggests that this is a 
fragment more prone to cleavage in the first methionine residues, thus originating high level of 
both PRRXL1107-263 and PRRXL1189-263. This observation correlates well with surface 
accessibility scores, according to which PRRXL1 N-terminal region containing the 
homeodomain is highly exposed [26,23]. In 2D electrophoretic analysis of PRRXL1-HA treated 
with prolonged CNBr incubation (fig. 5c), a new fragment encompassing aminoacids 212 
forward was detected. It still displayed the same number of phosphorylated spots (four) as the 
PRRXL1189-263 peptide, confirming that the majority of C-terminal phosphorylations occur from 
aminoacid 212 forward. 
One advantage of the CNBr chemical cleavage, in comparison with the truncation 
approach, is the use of full-length PRRXL1, which maintains its native conformation. Thus, 
contrary to the PRRXL1189-263 truncation (fig. 5a), the spot pattern of PRRXL1189-263 resulting 
from the CNBr cleavage was also vertically resolved, while the highly phosphorylated 
PRRXL1212-263 fragment was just horizontally resolved (fig. 5c). This indicates that this part of 
the protein may not suffer SDS-PAGE resistant conformational changes. Therefore, the data 
suggest that the structural alterations occurring in PRRXL1 must include the region up to 
aminoacid 212, and comprises most of the otp, aristaless and rax (OAR) domain. However, 
these structural changes were not visible in the PRRXL1189-263 truncation, which was never 
expressed in the presence of the N-terminus of the protein. Therefore, this may indicate that the 
N-terminal region is necessary for the induction of the mentioned structural changes. As the 
PRRXL1107-263 truncation was also vertically resolved, the region important for PRRXL1 
conformational changes to occur must be located between aminoacids 107 and 189. This can be 
further narrowed to region 107-143, as PRRXL11-143 was the smallest N-terminus truncation that 
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exhibited a conformation change. Overall, two phosphorylation clusters were identified, one 
encompassing aminoacids 1-143 and containing at least 2 phosphorylated residues, and other 
encompassing aminoacids 227-263, containing at least 4 phosphorylated residues. These regions 
likely have structural implications for the phosphorylation rich C-terminus.  
 
PRRXL1 C-terminal region contains a neuronal-specific repressing domain 
Protein phosphorylation has been described as an activity regulator of several 
transcription factors [27], which could also be the case for PRRXL1. RGMb is a protein whose 
expression is known to be regulated by PRRXL1 [15], and thus a luciferase reporter assay was 
used to measure PRRXL1 activity on the Rgmb promoter in ND7/23 and non-neuronal HeLa 
cell lines (fig. 6a). Comparison of PRRXL1 transcriptional activity with the control (empty 
vector) revealed a repressor function for PRRXL1 in both models. However, deletion of 
PRRXL1 C-terminus (aminoacids 227 to 263) diminished PRRXL1 repressor activity in 
ND7/23, but not in HeLa cells, which is suggestive of a neuronal-specific effect. As expected, 
PRRXL1107-263 and PRRXL1189-263 did not change basal promoter activity, since they lack the 
ability to bind DNA. 
When looking at DNA affinity (fig. 6b), a great reduction in DNA binding was observed 
in constructs with deletion of the homeodomain, as expected. Conversely, constructs lacking the 
C-terminus regulatory domain still maintained their ability to bind DNA (fig. 6b, PRRXL11-143). 
However, full-length PRRXL1 expressed in E. coli, where PRRXL1 is not phosphorylated or 
folded (fig. 1a), was also not able to bind DNA. This reinforces the role of phosphorylation on 
PRRXL1-DNA binding, and thus PRRXL1 activity as a transcription factor. 
 
 
DISCUSSION 
 
PRRXL1 is a paired-like homeodomain transcription factor with a crucial role in the 
differentiation, connection and maintenance of DRG and dSC pain-processing neurons during 
development [6]. However, the mechanisms governing PRRXL1 activity in nociceptive system 
development are unknown. This study shows that PRRXL1 is phosphorylated. These 
phosphorylated residues are located in two well defined functional domains: one encompassing 
aminoacids 1-143 and involved in conformational changes, and the other including aminoacid 
227 forward and displaying neuronal specific repressor activity (fig. 7). 
Protein phosphorylation is the most common post-translational modification in 
eukaryotes [9]. It is frequently used in signal transduction, and it is implicated in basic cellular 
processes such as metabolism, growth, division and differentiation [28]. In fact, several 
homeodomain proteins have been reported to be phosphorylated, such as Arix [27], Csx/Nkx2.5 
[12] and more recently Pax6 [29]. PRRXL1 acquires distinct phosphorylation patterns along SC 
and DRG development, with higher phosphorylation states at early developmental ages (from 
E10.5 to E14.5). At later stages, PRRXL1 is progressively less phosphorylated, thus acquiring a 
more compact and stable protein conformation with reduced transcriptional activity. Therefore, 
reversible phosphorylation and dephosphorylation can act as a molecular switch on PRRXL1 
function, with important impact on regulating diverse cellular functions, as occurs with several 
other proteins [30,31]. 
However, this change in phosphorylation state does not occur at similar time points in 
these tissues. PRRXL1 is maintained at a hyperphosphorylated state until later ages (P7) in the 
DRG when compared to the SC (E18.5). Moreover, while in the SC there is a progressive 
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conversion of bands 1/2 to band 4, PRRXL1 in the DRG progressively acquires a conformation 
corresponding to band 3 even at late post-natal ages. Thus, one may argue that specific 
phospho-sites are spatially and chronologically regulated. Considering that the anatomo-
functional abnormalities in Prrxl1
-/-
 mouse occur earlier in the dSC than in the DRG [6,32], this 
indicates that PRRXL1 might play different roles in different tissues, supporting the proposed 
PRRXL1 involvement in neuronal differentiation within the dSC, and in the DRG-spinal 
targeting within the DRG [32]. Mechanistically, this probably results from distinct 
phosphorylation states acquired by PRRXL1 during the different phases of DRG and SC 
neurodevelopment, which may promote the association of PRRXL1 with distinct molecular 
partners/promoter regions. The combinatorial interaction between various homeodomain 
transcription factors indeed commands the differentiation of SC and DRG neuronal 
subpopulations [3]. Differential expression of PRRXL1 with LMX1b and TLX3 in the dSC 
defined three different laminae I-III glutamatergic neuronal populations [32]. PRRXL1 could 
therefore be involved in this mechanism through phosphorylation. 
PRRXL1 has at least six phosphorylated residues, as determined by the 2D 
electrophoretic analysis of mouse SC and DRG tissue. These phosphorylations can be grouped 
in two clusters. Therefore, there are at least two phospho-sites between aminoacids 1-143 and 
four phospho-sites in the C-terminus (aminoacids 227-263). The most common phosphorylated 
aminoacid residues are phosphoserine and phosphothreonine [9], which is probably the case for 
PRRXL1. In fact, phosphoserine-binding domains have been described to play an important role 
in signal propagation, by enabling phosphorylation-dependent protein-protein interactions [11]. 
If this is the case for PRRXL1, such phosphorylated residues could play a role in PRRXL1 
signaling pathway. Additionally, protein kinases target many cellular proteins and can cause 
significant conformational changes. On the other hand, protein conformation is very important 
for kinase accessibility, and therefore for protein activity.  Therefore, PRRXL1 conformational 
changes must act as a mechanism to regulate the interaction between PRRXL1 and other 
proteins involved in the development of the nociceptive system. Phosphorylation seems to 
induce a less stable conformational change, and CNBr cleavage assays suggest that the N-
terminal is highly exposed, a condition important for PRRXL1-DNA binding. The structural 
alterations occurring in PRRXL1 result in a four band pattern upon SDS-PAGE.  This four band 
pattern results from two similar paired bands (bands 2/4 and the not so clearly visualized bands 
1/3) that likely result from phosphorylation at key residues. According to this work, some of 
these residues must be located in the region of PRRXL1 encompassing aminoacid residues 107-
143. 
It is known that PRRXL1 has an homeodomain and an OAR domain [33]. The 
homeodomain is a 60 aminoacid region that binds to palindromic DNA regulator sequences 
[34]. Here, a phosphorylation cluster encompassing this homeodomain was identified. 
Considering this proximity, it is hypothesized that this region may regulate PRRXL1-DNA 
binding events. This is further supported by the fact that PRRXL1 expressed in a prokaryotic 
system, and thus not phosphorylated, is not able to bind DNA. On the other hand, the OAR 
domain spans aminoacids 199-219 and is a transactivation domain whose function is not yet 
fully understood. However, in vivo and in vitro studies have shown that the deletion of the 
OAR domain in the Prx1/2 and Cart1 homeodomain proteins increases DNA binding and 
transcriptional activity [35-37]. Thereby, it has been proposed that the OAR domain negatively 
modulates the protein function, which may in this case be aided by the phosphorylation of 
PRRXL1 identified repressor domain. This negative regulation of transcriptional activity may 
also involve an intra-molecular interaction between the OAR and the DNA-binding 
homeodomain [35]. Since these two functional domains are located at opposite ends of the 
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PRRXL1 protein, an interaction between them will most likely require a structural loop, 
mediated through the phosphorylation of the conformation domain.  
Recently, the existence of a “post-translational modification code” has been proposed, in 
a way that the distinct combination of post-translational modifications could function as a 
molecular code, thus originating a large set of combinations from a limited set of elements and 
conveying different meanings or biological responses [38]. The existence of such a code could 
be extrapolated to a “phosphorylation code”, in that different combinations of phosphorylated 
residues would convey different molecular responses. In fact, this has already been described 
for the retinoblastoma tumor suppressor protein (Rb) [39]. It is known that different 
phosphorylated forms of Rb exist, and it was demonstrated that phosphorylation events induce 
unique conformations in Rb. These conformational changes are site specific and provide a 
mechanism through which different phosphorylation events can code for different functional Rb 
outputs [39]. This could also be true for PRRXL1, in a way that different combinations of 
phosphorylated residues could enable a wider and at the same time a more specific range of 
action. The existence of phosphorylated residues within a given PRRXL1 domain could further 
increase its transcriptional potential. Therefore, a putative PRRXL1 phosphorylation code could 
enable fine-tuning of transcriptional responses beyond a mere global modulation of transcription 
factor concentration, further augmenting PRRXL1 capabilities in the regulation of nociceptive 
system development. 
In conclusion, the present findings give important insight on phospho-dependent 
functioning of PRRXL1, and uncover a part of the vast mechanisms that take part in regulating 
PRRXL1 activity. However, the exact phosphorylated aminoacid residues will be invaluable for 
further study of the role of PRRXL1 in the development of the nociceptive system, and the 
ND7/23 cell line appears to be a suitable model for further studies on PRRXL1 transcriptional 
activity. 
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FIGURES, TABLE AND LEGENDS 
 
 
 
 
Fig. 1 – PRRXL1 multiple band pattern is the result of phosphorylation. a) Comparison of 
PRRXL1 expression pattern in Escherichia coli and in dSC from E14.5 and P0 mice. dSC 
extracts migrate as a multiple band pattern, while PRRXL1 expressed in E. coli migrates as a 
lower single band. b) PRRXL1 band pattern is a result of phosphorylation. Lysates from E14.5 
dSC were treated with different units (U) of CIAP in the presence (+) or absence (-) of a 
competitive inhibitor (Na2HPO4), resulting in progressive elimination of the multiple band 
pattern. c) Phosphoprotein enrichment by Ga(III) IMAC of protein lysates from E14.5 and P0 
dSC. The upper bands in all samples are enriched in the eluate. The control matrix (without 
Ga
3+
) did not bind PRRXL1. d) ND7/23 cell overexpressing Prrxl1 were incubated with CIAP, 
resulting in the abrogation of the multiple band pattern. e) Ga(III) IMAC of protein lysates from 
ND7/23 cells overexpressing PPRXL1 shows upper band enrichment.  
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Fig. 2 – PRRXL1 acquires distinct phosphorylation profiles along development. a) WB 
characterization of PRRXL1 band pattern at distinct dSC and DRG developmental ages. Loaded 
protein extracts were equilibrated to the overall PRRXL1 signal in order to highlight differences 
in the band pattern. As development progresses, the lower bands grow in relative abundance. 
Note that the lowest band in the DRG tissue is band number 3 (compare P21 DRG and E18.5 
dSC). b) 2D analyses of PRRXL1 from dSC (E14.5, E16.5, P0 and P14) and ND7/23 cells 
overexpressing PPRXL1. E14.5 dSC treated with CIAP was used to identify the PRRXL1 
dephosphorylated state. For each sample, a correspondence between the 2D differential spot 
pattern with the 1D SDS-PAGE band pattern was depicted in the diagram. The arrows indicate 
variation of particular spots along development. The number of phosphorylated residues was 
estimated by using the theoretical pI of multisite phosphorylated Prrxl1 and the 
dephosphorylated control (CIAP). NT: neural tube.  
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Table 1 - Ferguson plot analysis of PRRXL1 upper doublet vs lower doublet. 
 
 Mean Kr S.E.M. Y0 S.E.M. 
PRRXL1 (bands 1/2) -4.710 0.260 2.151 0.264 
PRRXL1 (bands 3/4) -4.830 0.269 2.308 0.282 
Average difference 0.121 0.010 0.156 0.022 
p 0.0062  0.008  
 
 
Table 1 – Ferguson plot analyses correlates PRRXL1 phosphorylation-induced gel shift with 
distinct protein shapes.  A linear regression of the logarithm of the relative electrophoretic 
mobility as a function of acrylamide concentration was performed. The table shows the slope 
(which corresponds to the retardation coefficient (Kr)) and the y-intercept (y0). Differences in 
Kr relate to differences in molecular radius while differences in y0 are related to differences in 
charge. This shows PRRXL1 phosphorylation induces a change in the molecular radius of 
PRRXL1. Kr: slope of electrophoretic mobility. S.E.M.: standard error of the mean. Y0: y-axis 
intercept. 
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Fig. 3 - PRRXL1 suffers phospho-dependent conformational changes. a) Limited tryptic 
proteolysis. ND7/23 extracts overexpressing Prrxl1 were treated with different amounts of 
trypsin and analyzed by WB. The graph represents the signal quantification of PRRXL1 upper 
(1/2) versus lower (3/4) bands. PRRXL1 upper bands are more prone to digestion, suggesting a 
more exposed conformation. b) PRRXL1 protein stability. ND7/23 cells overexpressing 
PRRXL1 were treated with cycloheximide and the PRRXL1 band abundance was assessed 
overtime by WB. The graph represents the signal quantification of PRRXL1 upper (1/2) versus 
lower (3/4) bands.  The results are representative of three independent experiments. 
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Fig. 4 – Analysis of PRRXL1 truncated forms. a) Schematic representation of HA-PRRXL1 
truncated forms. b) Immunocitochemistry of truncated versions of HA-PPRXL1. Anti-HA 
antibody stains the truncated forms in red, and DAPI stains the cellular nuclei in blue. Co-
localization of the two stains suggests nuclear translocation of the analyzed truncations. c) 
Subcellular fractionation of PRRXL1 constructs. The cytosolic and nuclear fraction were 
validated by using anti-tubulin and anti-histone H3 antibody respectively. d) Identification of 
PRRXL1 dimerization domain.  Co-immunoprecipitation studies with full-length PRRXL1-
FLAG and HA-PRRXL1 truncated forms reveal aminoacids 143-180 as the likely site for 
PRRXL1 homodimerization.  
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Fig. 5 – Mapping of PRRXL1 phosphorylated regions. a) 2D electrophoresis of ND7/23 
extracts overexpressing PRRXL1 truncated forms. b) Short CNBr cleavage assays (at 
methionine residues) were performed using overexpressed PRRXL1-HA and analyzed by WB 
with anti-HA antibody. The scheme represents theoretical PRRXL1 fragments, which were 
validated by comparison with the apparent size of the PRRXL1107-263 and   PRRXL1189-263 
constructs. The asterisk indicates a dimeric form of PRRXL1189-263. c) 2D electrophoretic 
analysis of ND7/23 cell extracts overexpressing PRRXL1-HA previously subjected to 
prolonged CNBr cleavage, revealing PRRXL1212-263. 
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Fig. 6 – PRRXL1 C-terminal contains a neuronal-specific repressor. a) Transcriptional activity 
of PRRXL1 truncations.  Luciferase assays on Rgmb promoter were performed with ND7/23 
and HeLa cells extracts expressing different PRRXL1 constructs. b) DNA-binding analysis of 
PRRXL1 truncations. ND7/23 cell extracts expressing different PRRXL1 truncations and 
recombinant PRRXL1 purified from E. coli were processed for DNA pull-down plate assays in 
the presence or absence (control) of a biotinylated Rgmb promoter probe. Values are represented 
as fold enrichment relative to the control sample.  
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Fig. 7 – Schematic representation of PRRXL1 functional domains and the location of putative 
phosphorylated regions. 
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Supplementary Table 1 
 
 
Construct Lower (Forward) Upper (reverse) 
PRRXL1 (for 
pGEX-4T3 cloning) 
CCGGAATTCCATGTTTTATTTCCA
CTGTCCGCCAC 
ATAGTTTAGCGGCCGCTCATACA
CTCTTCTCTCCCTC 
PRRXL1-HA 
GGAATTCGCCACCATGTTTTATTT
CCACTGTCCGCCAC 
TCAAGCGTAATCTGGAACATCGT
ATGGGTATACACTCTTCTCTC 
PRRXL1-FLAG 
TCATTTATCGTCATCGTCTTTGTA
GTCTGCGGCCTGTACACTCTTCTC
TC 
PRRXL1 GCTCTAGATCATACACTCTTCTCT
CCC HA-PRRXL1 
CGCCACCATGTACCCATACGATGT
TCCAGATTACGCTTTTTATTTCCA
CTGTCCGCC 
HA - PRRXL11-143 TCACACTGTGCGTCCCAGGCT 
HA - PRRXL11-180 GCACAGTGGGCCCCCTTT 
HA - PRRXL11-227 CAGGAGGTTGGCAGACTG 
HA - PRRXL1107-263 
CGCCACCATGTACCCATACGATGT
TCCAGATTACGCTGCAGAGGTGA
CACCACCG 
GCTCTAGATCATACACTCTTCTCT
CCC 
HA - PRRXL1189-263 
CGCCACCATGGGACTCTCCTTCCT
C 
 
Supplementary Table 1. Primers used for cloning all studied constructs.  
 
 













